Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
申请人:Neurogen Corporation
公开号:US06221871B1
公开(公告)日:2001-04-24
Disclosed are compounds of the formula:
where
S and V are various organic or inorganic substituents;
G and K are the same or different and represent N or CR′ where R′ is an organic or inorganic substituent;
R is hydrogen or an alkyl group;
R1, X, Y, Z and T are organic or inorganic substituents; and
R2 and R3 represent hydrogen or organic substituents; or
NR2R3 together represents a heterocyclic ring system;
and the pharmaceutically acceptable salts thereof; which are highly selective partial agonists or antagonists at brain dopamine receptor subtypes and, thus, are useful in the diagnosis and treatment of affective disorders such as schizophrenia and depression as well as certain movement disorders such as Parkinsonism.
本发明涉及一种化合物,其化学式为:其中S和V是不同的有机或无机取代基;G和K相同或不同,代表N或CR',其中R'是有机或无机取代基;R是氢或烷基;R1、X、Y、Z和T是有机或无机取代基;R2和R3代表氢或有机取代基;或NR2R3一起代表一个杂环环系统;以及其药学上可接受的盐;该化合物是高度选择性的部分激动剂或拮抗剂,在大脑多巴胺受体亚型上,因此,在诊断和治疗情感障碍(如精神分裂症和抑郁症)以及某些运动障碍(如帕金森症)方面非常有用。